DGX
$95.04
Quest Diagnostics
($1.03)
(1.07%)
DGX
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  $1.60
Revenue:  $1.93 Bil
Tuesday
Jan 22
6:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DGX reports earnings?
Beat
Meet
Miss

Where is DGX's stock price going from here?
Up
Flat
Down
Stock chart of DGX
Analysts
Summary of analysts' recommendations for DGX
Score
Grade
Pivots
Resistance
$98.80
$97.75
$96.40

$95.35

Support
$94.00
$92.95
$91.60
Tweet
Growth
Description
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Peers
Laboratory Corp. of America